Cover Image
市場調查報告書

核醫學設備的全球市場 - 2020年為止的預測:各產品 (SPECT、混合PET、平面顯像)、用途、終端用戶

Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), Application (Cardiology, Oncology & Neurology) & by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020

出版商 MarketsandMarkets 商品編碼 339588
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
Back to Top
核醫學設備的全球市場 - 2020年為止的預測:各產品 (SPECT、混合PET、平面顯像)、用途、終端用戶 Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), Application (Cardiology, Oncology & Neurology) & by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020
出版日期: 2015年09月11日 內容資訊: 英文 161 Pages
簡介

過去數年,核醫學設備市場為了對應患者及放射線科醫生的需求在產品及認證中達成各種演進。2015年,北美預計有全球核醫學設備市場最大的佔有率。今後預計成為亞太地區最大的成長率。

本報告提供重症肌無力的流行病學、病因、病理學、症狀、診斷、治療指南等概要,以及市場收益與到2024年的預測、未滿足需求開發平台分析、市場上競爭趨勢等彙整資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場趨勢
    • 促進要素
      • 新廠及演進型產品的引進
      • 透過官民合作關係對診斷用影像中心現代化的投資
      • 放射線描繪器的演進
      • 癌症及心臟病的發病率,罹患率的常勝
      • 高齡化
      • 共球性政府機關的投資,增加融資、津貼
    • 阻礙要素
      • 核醫學設備的成本高
      • 放射性醫藥品的半衰期短
    • 課題
      • 改良的診斷用影像系統的引進擴大
      • 醫院的預算切割
    • 機會
      • 堅固的產品平台
      • 新興市場上高需求

第6章 各產品市場

  • 簡介
  • SPECT
  • 混合PET
  • 平面顯像

第7章 各用途市場

  • 簡介
  • 心臟
  • 腫瘤
  • 神經
  • 其他

第8章 各終端用戶市場

  • 簡介
  • 醫院
  • 影像中心
  • 學術機構、研究機關
  • 其他

第9章 各地區市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭趨勢

第11章 企業簡介

  • 簡介
  • PHILIPS HEALTHCARE
  • SIEMENS AG (SIEMENS HEALTHCARE)
  • GE HEALTHCARE
  • DIGIRAD CORPORATION
  • MEDISO MEDICAL IMAGING SYSTEMS LTD.
  • SURGICEYE GMBH
  • 東芝MedicalSystems株式會社
  • DDD-DIAGNOSTIC A/S
  • NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • CMR NAVISCAN CORPORATION

第12章 附錄

圖表

目錄
Product Code: MD 3732

Over the years, the nuclear medicine equipment market has witnessed various advancements in products and their approvals to meet the needs of patients and the radiologists. These advancements have led to the improved use of many existing nuclear medicine equipment as well as the introduction of some new ones.

In 2015, the SPECT systems are expected to account for the largest share of nuclear medicine equipment market, by product; in the SPECT segment the hybrid SPECT systems are likely to command the largest share and are expected to grow at a highest CAGR during the forecast period. Cardiology application segment is expected to account for the largest share of the global nuclear medicine equipment market, by application; the hospitals segment is expected to account for the largest share of the global nuclear medicine equipment market, by end user. Increased adoption of nuclear imaging equipment by hospitals around the world is a major factor for the large share hospitals in the global nuclear medicine equipment market.

In 2015, North America is expected to account for the largest share of the global nuclear medicine equipment market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the nuclear medicine equipment market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in this region can be attributed to increasing research and development investments, expansion of international players and increasing disease burden and favorable regulatory framework.

The global nuclear medicine equipment market is witnesses' high competitive intensity with Siemens Healthcare (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.K.) being the market leaders. Other players include Mediso Medical Imaging Systems, Ltd. (Hungary), Toshiba Medical Systems Corporation (Japan), DDD-Diagnostics A/S (Denmark), Neusoft Medical Systems Co. Ltd. (China), SurgicEye GmbH (Germany), and CMR Naviscan Corporation (U.S.), among others. The players in this market have implemented various strategies to expand their global footprint and increase their market share. The key strategies followed by most of the companies in the nuclear medicine equipment include agreements/partnerships/alliances/collaborations; new product launches; expansions and others.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater markest share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nuclear medicine equipment market. The report analyzes the nuclear medicine equipment market, by product, application, and end user.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, product approvals, and new product launches in the nuclear medicine equipment market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various nuclear medicine equipment across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the nuclear medicine equipment market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nuclear medicine equipment market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key Insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. CURRENT SCENARIO
  • 3.2. FUTURE OUTLOOK
  • 3.3. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET
  • 4.2. NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION AND END USER

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Introduction of new and advanced products
      • 5.3.1.2. Investments through public-private partnerships to modernize diagnostic imaging centers
      • 5.3.1.3. Advances in radiotracers
      • 5.3.1.4. Increasing incidence and prevalence of cancer and cardiac ailments
      • 5.3.1.5. Growing geriatric population
      • 5.3.1.6. Increasing investments, funds, and grants by government bodies worldwide
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of nuclear medicine equipment
      • 5.3.2.2. Shorter half-life of radiopharmaceuticals
    • 5.3.3. CHALLENGES
      • 5.3.3.1. Increasing adoption of refurbished diagnostic imaging systems
      • 5.3.3.2. Hospital budget cuts
    • 5.3.4. OPPORTUNITIES
      • 5.3.4.1. Strong product pipeline
      • 5.3.4.2. High demand in emerging markets

6. NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)
    • 6.2.1. STANDALONE SPECT SYSTEMS
    • 6.2.2. HYBRID SPECT SYSTEMS
  • 6.3. HYBRID PET
  • 6.4. PLANAR SCINTIGRAPHY

7. NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CARDIOLOGY
  • 7.3. ONCOLOGY
  • 7.4. NEUROLOGY
  • 7.5. OTHER APPLICATIONS

8. NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. IMAGING CENTERS
  • 8.4. ACADEMIC AND RESEARCH CENTERS
  • 8.5. OTHER END USERS

9. NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Increased adoption of nuclear medicine equipment
      • 9.2.1.2. Increase in the aging population and rising prevalence of chronic diseases
      • 9.2.1.3. Declining reimbursements for radiology
      • 9.2.1.4. Unfavorable healthcare reforms
    • 9.2.2. CANADA
      • 9.2.2.1. High incidence rate chronic diseases
  • 9.3. EUROPE
    • 9.3.1. EU5
      • 9.3.1.1. Increasing number of PET-CT procedures in the U.K.
      • 9.3.1.2. Increasing adoption of nuclear medicine equipment
      • 9.3.1.3. Increasing incidence and prevalence of cancer
      • 9.3.1.4. Increasing investment by stakeholders
      • 9.3.1.5. Sluggish growth in healthcare expenditure
    • 9.3.2. ROE
      • 9.3.2.1. Government and public-private investments
      • 9.3.2.2. Increased focus of market players
      • 9.3.2.3. Rapid rise in the geriatric population
  • 9.4. ASIA-PACIFIC (APAC)
    • 9.4.1. JAPAN
      • 9.4.1.1. Aging population and high healthcare expenditure in Japan
    • 9.4.2. CHINA
      • 9.4.2.1. Developing healthcare infrastructure
      • 9.4.2.2. Rise in population, prevalence of diseases
      • 9.4.2.3. Irregularities in the tendering process
    • 9.4.3. INDIA
      • 9.4.3.1. High incidence and prevalence of chronic diseases
      • 9.4.3.2. Increasing installations of nuclear medicine equipment
      • 9.4.3.3. Increasing focus of global market players
      • 9.4.3.4. Improving healthcare insurance coverage
      • 9.4.3.5. Increasing use of refurbished medical devices a major challenge for market players
    • 9.4.4. REST OF ASIA-PACIFIC (ROAPAC)
      • 9.4.4.1. Increasing incidence of chronic disease, growing geriatric population
      • 9.4.4.2. Favorable regulatory changes in New Zealand and Australia
      • 9.4.4.3. Increasing public-private investments
  • 9.5. REST OF THE WORLD
    • 9.5.1. LATIN AMERICA
      • 9.5.1.1. Favorable reimbursement scenario in Brazil
      • 9.5.1.2. Consolidation of healthcare service providers in Brazil
      • 9.5.1.3. Growing healthcare infrastructure in Latin America
    • 9.5.2. THE MIDDLE EAST
    • 9.5.3. AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES
    • 10.3.2. EXPANSIONS
    • 10.3.3. ACQUISITIONS
    • 10.3.4. OTHER STRATEGIES

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. PHILIPS HEALTHCARE
  • 11.3. SIEMENS AG (SIEMENS HEALTHCARE)
  • 11.4. GE HEALTHCARE
  • 11.5. DIGIRAD CORPORATION
  • 11.6. MEDISO MEDICAL IMAGING SYSTEMS LTD.
  • 11.7. SURGICEYE GMBH
  • 11.8. TOSHIBA MEDICAL SYSTEMS CORPORATION
  • 11.9. DDD-DIAGNOSTIC A/S
  • 11.10. NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • 11.11. CMR NAVISCAN CORPORATION

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2012-2015)
    • 12.2.1. PHILIPS HEALTHCARE
    • 12.2.2. SIEMENS HEALTHCARE
    • 12.2.3. GE HEALTHCARE
    • 12.2.4. DIGIRAD CORPORATION
    • 12.2.5. TOSHIBA MEDICAL SYSTEMS CORPORATION
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INTRODUCTION OF ADVANCED PRODUCTS IS DRIVING THE GROWTH OF THE NUCLEAR MEDICINE EQUIPMENT MARKET
  • TABLE 2: HIGH COST OF NUCLEAR MEDICINE EQUIPMENT RESTRAINING MARKET GROWTH
  • TABLE 3: GROWING ADOPTION OF REFURBISHED SYSTEMS IS A MAJOR CHALLENGE FOR THE NUCLEAR MEDICINE EQUIPMENT MARKET
  • TABLE 4: EMERGING MARKETS PRESENT AN ARRAY OF OPPORTUNITIES FOR GROWTH OF THE NUCLEAR MEDICINE EQUIPMENT MARKET
  • TABLE 5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 6: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (UNITS)
  • TABLE 7: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 9: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (UNITS)
  • TABLE 10: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR STANDALONE SPECT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HYBRID SPECT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HYBRID PET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR PLANAR SCINTIGRAPHY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 15: HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 16: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 17: PLANAR SCINTIGRAPHY SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 18: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR CARDIOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR ONCOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR NEUROLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 23: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR IMAGING CENTERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 29: NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 30: NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 32: NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 33: U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 34: U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 35: U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 36: U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 37: CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 38: CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 39: CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 40: CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 41: EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 42: EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 43: EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 45: EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 46: EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 47: EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 50: ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 51: ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 55: APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 58: APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 62: JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 63: CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 67: INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 68: INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 70: INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 71: ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 72: ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 73: ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 74: ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 75: ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 76: ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 77: ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 78: ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 79: AGREEMENTS, JOINT VENTURES, PARTNERSHIPS, COLLABORATIONS, AND ALLIANCES, 2012-2015
  • TABLE 80: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 81: EXPANSIONS, 2012-2014
  • TABLE 82: ACQUISITIONS, 2012-2015
  • TABLE 83: OTHER STRATEGIES, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL NUCLEAR MEDICINE EQUIPMENT MARKET IN 2015
  • FIGURE 9: HYBRID PET SEGMENT TO WITNESS HIGHEST GROWTH IN THE NUCLEAR MEDICINE EQUIPMENT MARKET BETWEEN 2015 & 2020
  • FIGURE 10: ASIA-PACIFIC IS EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 11: NUCLEAR MEDICINE EQUIPMENT MARKET OVERVIEW
  • FIGURE 12: CARDIOLOGY SEGMENT TO DOMINATE THE MARKET IN 2015
  • FIGURE 13: ASIA-PACIFIC POISED TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: NUCLEAR MEDICINE EQUIPMENT: MARKET SEGMENTATION
  • FIGURE 15: NUCLEAR MEDICINE EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: SPECT SEGMENT WILL CONTINUE TO DOMINATE THE NUCLEAR MEDICINE EQUIPMENT MARKET
  • FIGURE 17: CARDIOLOGY SEGMENT IS EXPECTED TO DOMINATE THE NUCLEAR MEDICINE EQUIPMENT MARKET IN 2015
  • FIGURE 18: HOSPITALS SEGMENT PROJECTED TO ACCOUNT FOR MORE THAN 1/3RD OF THE TOTAL NUCLEAR MEDICINE EQUIPMENT MARKET
  • FIGURE 19: SHARE OF GERIATRIC POPULATION IN THE TOTAL POPULATION, 2010 VS. 2030
  • FIGURE 20: NUMBER OF NEW CANCER CASES, BY COUNTRY, 2012 VS. 2020
  • FIGURE 21: INCREASING PREVALENCE OF CANCER IS DRIVING THE MARKET GROWTH IN NORTH AMERICA
  • FIGURE 22: NORTH AMERICAN MARKET SNAPSHOT
  • FIGURE 23: EUROPE: NUMBER OF CANCER CASES REPORTED, BY COUNTRY
  • FIGURE 24: EUROPEAN MARKET SNAPSHOT
  • FIGURE 25: NUMBER OF NEW CANCER CASES, BY TYPE
  • FIGURE 26: ASIA-PACIFIC MARKET SNAPSHOT: CHINA, THE FASTEST-GROWING COUNTRY IN THE NUCLEAR MEDICINE EQUIPMENT MARKET
  • FIGURE 27: ROW MARKET SNAPSHOT
  • FIGURE 28: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2012 & 2015
  • FIGURE 29: GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 30: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 31: KEY PLAYERS FOCUSING ON AGREEMENTS, COLLABORATIONS, JOINT VENTURES, ALLIANCES, AND PARTNERSHIPS, 2012-2015
  • FIGURE 32: KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2012-2015
  • FIGURE 33: KEY PLAYERS FOCUSING ON EXPANSIONS, 2012-2015
  • FIGURE 34: KEY PLAYERS FOCUSING ON ACQUISITIONS, 2012-2015
  • FIGURE 35: KEY PLAYERS FOCUSING ON OTHER STRATEGIES, 2012-2015
  • FIGURE 36: GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS
  • FIGURE 37: PHILIPS HEALTHCARE : COMPANY SNAPSHOT
  • FIGURE 38: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 39: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 40: DIGIRAD CORPORATION
  • FIGURE 41: TOSHIBA MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT
Back to Top